A pan-cancer analysis of the microbiome in metastatic cancer - Vivek Subbiah, MD
Antonio Carlos Cell Press

#AACR24 #Cancer #FDA #Fusobacterium #MetastaticCancer #NSCLC #OncoDaily #Oncology #Cancer Research

oncodaily.com/47587.html

Very pleased to present our results on the 1st evidence of the tissue #NanomechanicalSignature as a potent novel tool for the diagnosis and prognosis assessment in pts with #NSCLC at #AACR2024 🚀
It's been a pleasure discussing them with you all!👩🏼‍🔬
Noemi Reguart Jordi Alcaraz UB Hector Sanz, Ph.D.

We can't wait to have Dr. Balazs Halmos back on the mic discussing 'Rechallenge with Immunotherapy in NSCLC' at #TexasLung24 . Come be part of the discussions and hear from leading experts in #LungCancer ! hubs.ly/Q02s9_TK0 #cme

Results of adjuvant Alectinib vs Chemotherapy in resected ALK+ stage IB-IIIA NSCLC - Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation
NEJM Mayo Clinic

#ClinicalTrials #Cancer #Chemotherapy #NEJM #NSCLC #OncoDaily #Oncology

oncodaily.com/48017.html

Original Article: Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer (ALINA) nej.md/3VUzf3M

Editorial: Adjuvant Alectinib in ALK-Rearranged NSCLC — Here and Now nej.md/43WM3bU

#Oncology

CEO Vlad Vitoc was featured in Oncology Compass’s April Issue to discuss our cancer telomere targeting agent THIO, ongoing phase 2 trial data evaluating THIO-101 in patients with #NSCLC , 100% DCR in 2nd line and more. Dive into how THIO works here: bit.ly/43ZqnMg $MAIA

Now up at #AILCC24 is Cathryn Crockett 💙 from Belfast Trust giving a superb overview of #SABR in early stage #NSCLC

Discusses ongoing studies and recent use of adjuvant #immunotherapy

A tour de force presentation by Mr Ronan Ryan St James's Hospital Trinity St James's Cancer Institute on novel surgical tools & techniques in early stage #NSCLC #AILCC24 IASLC #IrishLungCancerCommunity #LCSM

Thrilled to present our poster at #AACR24 exploring the role of gut microbiota in shaping chemo-immunotherapy outcomes for locally advanced NSCLC 🦠🦠 LiquidBiopsyLabPdH

Some guidance on the management of adverse events with sotorasib in KRAS G12C NSCLC Lung Cancer Journal - Stephen V Liu, MD
Lung Cancer Journal MedStar Georgetown

#Cancer #LungCancer #NSCLC #OncoDaily #Oncology #Cancer Research #Cancer Therapy

oncodaily.com/47496.html

🚨 Don't miss the latest from OncoAlert! 📰
✅ U.S. FDA gives green light to trastuzumab dx 🇺🇸 ✅ Impact of Durvalumab on small cell lung cancer 🫁 ✅ ALINA study results in #NSCLC on NEJM
Plus, CD70 CART in #KidneyCancer , Adagrasib Cetux 💊 in #ColorectalCancer , and more…

Thoughtful discussion by Marina Garassino on the use of liquid biopsy to guide treatment decisions for patients with #NSCLC and #EGFR mutations. #AACR24

Excited to share our paper on Precision Immuno-Oncology in NSCLC through Gender Equity Lenses - #FlorezLab
Jennifer Marks, MD Arthi Sridhar MDPI

#Cancer #NSCLC #OncoDaily #Oncology #PrecisionMedicine #ImmunoOncology #GenderEquity

oncodaily.com/47484.html

Very exciting to see in resected #ALK #NSCLC patients particularly the CNS HR data. Still need to see how data matures but certainly practice changing.

First published article in the 2024 ASCO Educational Book - Nathan A. Pennell MD, PhD, FASCO

oncodaily.com/45740.html

#oncodaily #NSCLC #EGFRmutation #cancerresearch #precisionmedicine #ASCO #qualityoflife #biomarkers #treatmentstrategies

Ready for a modern take on #LungCancer & thoracic oncology treatment? Then make sure you check out #BTOG24 on 17-19 April 🫁

Stay tuned with VJOncology.com for in-person expert interviews 🎥

Register 👉ow.ly/jwJe50Rfrn9

BTOG #LCSM #NSCLC #SCLC #LungCancer

Don't miss the ASCO Educational Book on novel treatment strategies for those with #EGFR -mutant #NSCLC across all stages 🫁

#OpenAccess book by Stephanie Saw, Xiuning Le MD PhD, Lizza Hendriks and Jordi Remon ⬇️

Thoughtful answers to some very tough audience questions at the #PLCClive24 early stage NSCLC session with Drs. Tina Cascone, Angel Qin, Pamela Samson, MD, Erin Schenk, MD, PhD, Brendon Stiles, Heather Wakelee - MedscapeLIVE #LCSM

Our very own Jarushka Naidoo presents a comprehensive overview of systemic therapy in Stage III NSCLC #Pacific #AILCC24 IASLC #IrishLungCancerCommunity #LCSM

JUST OUT on NEJM
Among patients with resected🧬ALK-positive #NSCLC 🫁of stage IB, II, or IIIA, adjuvant alectinib 💊

✅Significantly improved disease-free survival 🆚 platinum-based chemotherapy

nejm.org/doi/full/10.10…

Christian Rolfo gilberto lopes Narjust Florez, MD, FASCO Stephen V Liu, MD…